These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 16081048

  • 41. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
    Amin HM, McDonnell TJ, Ma Y, Lin Q, Fujio Y, Kunisada K, Leventaki V, Das P, Rassidakis GZ, Cutler C, Medeiros LJ, Lai R.
    Oncogene; 2004 Jul 15; 23(32):5426-34. PubMed ID: 15184887
    [Abstract] [Full Text] [Related]

  • 42. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, Monti E.
    Cancer Lett; 2007 Dec 18; 258(2):181-8. PubMed ID: 17920763
    [Abstract] [Full Text] [Related]

  • 43. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
    Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D.
    Cancer Res; 2006 Feb 15; 66(4):2028-37. PubMed ID: 16489002
    [Abstract] [Full Text] [Related]

  • 44. [Significance of phosphorylation of mitogen-activated protein kinase and signal transducer and activator of transcription 3 and cyclin D1 protein expression in Hodgkin's lymphomas].
    Luo HY, Wang HC, Li YN, Zheng H.
    Ai Zheng; 2003 Mar 15; 22(3):266-9. PubMed ID: 12654183
    [Abstract] [Full Text] [Related]

  • 45. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1238-47. PubMed ID: 16954476
    [Abstract] [Full Text] [Related]

  • 46. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B, Bianchi F, Dey J, Moreno E, Djaffer S, Hynes NE, Monard D.
    Cancer Res; 2009 Jul 15; 69(14):5690-8. PubMed ID: 19584287
    [Abstract] [Full Text] [Related]

  • 47. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis.
    Svensson S, Jirström K, Rydén L, Roos G, Emdin S, Ostrowski MC, Landberg G.
    Oncogene; 2005 Jun 23; 24(27):4370-9. PubMed ID: 15806151
    [Abstract] [Full Text] [Related]

  • 48. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
    Ye LH, Wu LY, Guo W, Ma HT, Zhang XD.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 03; 86(1):61-5. PubMed ID: 16606541
    [Abstract] [Full Text] [Related]

  • 49. [Effects of Stat3 phosphorylation and expression of c-fos and c-jun proteins on hepatocarcinogenesis].
    Feng DY, Zheng H, Jiang HY.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Feb 28; 26(1):17-9. PubMed ID: 12536605
    [Abstract] [Full Text] [Related]

  • 50. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.
    Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571
    [Abstract] [Full Text] [Related]

  • 51. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
    Int J Oncol; 2005 Oct 01; 27(4):949-56. PubMed ID: 16142310
    [Abstract] [Full Text] [Related]

  • 52. Stat3 upregulates MEK5 expression in human breast cancer cells.
    Song H, Jin X, Lin J.
    Oncogene; 2004 Oct 28; 23(50):8301-9. PubMed ID: 15378007
    [Abstract] [Full Text] [Related]

  • 53. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y, Tong D, Lou G, Zhang Y, Geng J.
    Pathobiology; 2008 Oct 28; 75(4):244-51. PubMed ID: 18580070
    [Abstract] [Full Text] [Related]

  • 54. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
    Liu HJ, Moroi Y, Masuda T, Yasumoto S, Kokuba H, Imafuku S, Koga T, Tetsuya T, Tu YT, Aburatani H, Furue M, Urabe K.
    Br J Dermatol; 2006 May 28; 154(5):926-32. PubMed ID: 16634897
    [Abstract] [Full Text] [Related]

  • 55. [Correlation between Stat3 signal transduction pathway and expression of cyclooxygenase-2 in colorectal cancer cells].
    Zhang H, Wang S, Zhang YC, Ye YJ, Cui ZR, Fang WG.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 02; 85(41):2899-904. PubMed ID: 16324362
    [Abstract] [Full Text] [Related]

  • 56. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.
    Breast Cancer Res Treat; 2007 Mar 02; 101(3):279-84. PubMed ID: 16835704
    [Abstract] [Full Text] [Related]

  • 57. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, Inamoto T, Takahara S, Itoh Y, Otsuki Y, Katsuoka Y, Miyazono K, Horie S.
    J Natl Cancer Inst; 2005 Dec 07; 97(23):1734-46. PubMed ID: 16333029
    [Abstract] [Full Text] [Related]

  • 58. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Nakao K, Nakamura M, Kakudo K.
    Clin Cancer Res; 2006 Feb 15; 12(4):1201-7. PubMed ID: 16489074
    [Abstract] [Full Text] [Related]

  • 59. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS, Kim SW.
    Oncol Rep; 2007 Jul 15; 18(1):139-43. PubMed ID: 17549359
    [Abstract] [Full Text] [Related]

  • 60. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
    Xi S, Gooding WE, Grandis JR.
    Oncogene; 2005 Feb 03; 24(6):970-9. PubMed ID: 15592503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.